Explore

Trendline Trendline
Verastem Oncology to Announce Q1 2026 Financial Results with Business Updates

Verastem Oncology to Announce Q1 2026 Financial Results with Business Updates

Verastem Oncology to Announce Q1 2026 Financial Results with Business Updates
Trendline Trendline
PureTech Announces Positive Results from Phase 1b Trial of LYT-200 for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

PureTech Announces Positive Results from Phase 1b Trial of LYT-200 for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

PureTech Announces Positive Results from Phase 1b Trial of LYT-200 for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
Trendline Trendline
Zai Lab to Announce Q1 2026 Financial Results and Corporate Updates

Zai Lab to Announce Q1 2026 Financial Results and Corporate Updates

Zai Lab to Announce Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Calluna Pharma Completes Enrollment in Global Phase 2 Study for Pulmonary Fibrosis Treatment

Calluna Pharma Completes Enrollment in Global Phase 2 Study for Pulmonary Fibrosis Treatment

Calluna Pharma Completes Enrollment in Global Phase 2 Study for Pulmonary Fibrosis Treatment
Trendline Trendline
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Regulatory Submissions

Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Regulatory Submissions

Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Regulatory Submissions
Trendline Trendline
Forlong Biotechnology to Present Clinical Data on FL115 for Advanced Solid Tumors at ASCO 2026

Forlong Biotechnology to Present Clinical Data on FL115 for Advanced Solid Tumors at ASCO 2026

Forlong Biotechnology to Present Clinical Data on FL115 for Advanced Solid Tumors at ASCO 2026
Trendline Trendline
Zai Lab to Announce First Quarter 2026 Financial Results and Corporate Updates

Zai Lab to Announce First Quarter 2026 Financial Results and Corporate Updates

Zai Lab to Announce First Quarter 2026 Financial Results and Corporate Updates
Trendline Trendline
Inhibrx Announces Webcast for Clinical Update on Ozekibart in Colorectal Cancer

Inhibrx Announces Webcast for Clinical Update on Ozekibart in Colorectal Cancer

Inhibrx Announces Webcast for Clinical Update on Ozekibart in Colorectal Cancer
Trendline Trendline
FDA Grants Fast Track Designation to Debiopharm's Ovarian Cancer Therapy

FDA Grants Fast Track Designation to Debiopharm's Ovarian Cancer Therapy

FDA Grants Fast Track Designation to Debiopharm's Ovarian Cancer Therapy
Trendline Trendline
Forlong Biotechnology to Present Clinical Data on FL115 at ASCO 2026

Forlong Biotechnology to Present Clinical Data on FL115 at ASCO 2026

Forlong Biotechnology to Present Clinical Data on FL115 at ASCO 2026
Trendline Trendline
Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Submissions

Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Submissions

Incyte Presents Phase 3 Tafasitamab Data at ASCO 2026, Supporting Global Submissions
Trendline Trendline
Exelixis to Announce Q1 2026 Financial Results with Conference Call and Webcast

Exelixis to Announce Q1 2026 Financial Results with Conference Call and Webcast

Exelixis to Announce Q1 2026 Financial Results with Conference Call and Webcast